Search clinical trials for: Annona Muricata

Total 52 results

Centre Hospitalier Universitaire de Pointe-a-Pitre

Recruiting

Epidemiology and Pathophysiology of Parkinsonism in the Caribbeans (CAP)

Atypical Parkinsonism

Martinique, French Guiana
Yaounde Central Hospital

Completed

Evaluation of an Antihypertensive Food Supplement Based on Aqueous Extract From Annona Muricata Sheets (AM-HTN)

Hypertension

Cameroon
University of Messina

Completed

A New Supplement for the Immune Response to HPV Infection

HPV Infection
Indonesia University

Completed

Effect of Annona Muricata Leaves on Colorectal Cancer Patients and Colorectal Cancer Cells

Colorectal Cancer
AstraZeneca

Recruiting

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

Chronic Kidney Disease and Hypertension

Spain, United States, Argentina, Denmark, Italy, Sweden, United Kingdom, Belgium, France, Turkey, China, Germany, Saudi Arabia, Thailand, Vietnam, Australia, Serbia, Brazil, Canada, Japan, Malaysia, Philippines, Poland, Taiwan, Greece, Is... and more
Centre Hospitalier Universitaire de Saint Etienne

Not yet recruiting

Can a Patient in Intensive Care be Visited by His or Her Pet? (ACCOMPAGNE)

Intensive Care Patients

France
Hoffmann-La Roche

Recruiting

A Study to Evaluate the Efficacy and Safety of RO7434656 in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression (IMAGINATION)

Primary IgA Nephropathy

Korea, Republic of, Australia, Spain, United Kingdom, Taiwan, China, Japan, France, United States, Italy, Greece, Czechia, Singapore, Argentina, Germany, Brazil, Poland, Canada
Novo Nordisk A/S

Recruiting

REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels (REDEFINE 3)

Cardiovascular Disease

Netherlands, Australia, Italy, United States, Serbia, Spain, United Kingdom, Thailand, India, Malaysia, Turkey, Mexico, Canada, Argentina, Germany, France, Poland, South Africa, Brazil, Bulgaria, Colombia, Denmark, Ireland, Japan
AstraZeneca

Recruiting

Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study (CONTINUITY)

Chronic Kidney Disease | Hyperkalaemia

Spain, United Kingdom, Belgium, Italy, Netherlands, France, Germany
Centre Hospitalier Universitaire de Saint Etienne

Recruiting

Efficiency of an Optimized Care Organization for Fibromyalgia Patients. The FIMOUV 2 Study (FIMOUV 2)

Physical Activity | Fibromyalgia

France
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Recruiting

Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers (CIBERSTAPH)

Hemodialysis Patients

France
Novo Nordisk A/S

Active, not recruiting

A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease (FLOW)

Diabetes Mellitus, Type 2

Spain, United Kingdom, United States, Australia, India, Canada, Turkey, Netherlands, Italy, Poland, China, Germany, Malaysia, Israel, Hungary, Ukraine, Japan, South Africa, Russian Federation, Brazil, France, Bulgaria, Belgium, Thailand, Gree... and more
GlaxoSmithKline

Completed

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

Anaemia

United States, Australia, Korea, Republic of, Spain, Taiwan, Bulgaria, Canada, Italy, Russian Federation, Ukraine, Argentina, Belgium, France, Philippines, South Africa, Thailand, Israel, Sweden, Singapore, Czechia, Hong Kong, Net... and more
University Hospital, Brest
Institut National de la Santé Et de la Recherche Médicale, France; Central...

Completed

ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial (ALCHEMIST)

End Stage Renal Failure on Dialysis

France, Belgium, Monaco
Intergroupe Francophone de Cancerologie Thoracique

Completed

French Biological Observatory on Lung Cancer in Never Smokers (BioCAST)

Lung Cancer

France
AstraZeneca

Completed

A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia (SAPPHIRE)

Chronic Kidney Disease

United States, Italy, Spain, France, Czechia, Israel, Slovakia, South Africa, Hungary, Poland, Mexico, Romania
GlaxoSmithKline

Completed

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

Anaemia | Aspergillosis, Allergic Bronchopulmonary

Australia, Korea, Republic of, Spain, United States, Taiwan, Bulgaria, Mexico, Ukraine, Argentina, Belgium, South Africa, Singapore, Austria, Canada, Netherlands, Russian Federation, Sweden, Turkey, United Kingdom, Germany, Romania and more
Centre Hospitalier Universitaire de Saint Etienne

Completed

Comparison of Blood Pressure Control Achieved in Antihypertensive or Generic Drugs in Moderate to Severe Hypertensive Patients (PRINGEN)

Hypertension

France
Hoffmann-La Roche

Completed

A Study of Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis.

Anemia

France
Hoffmann-La Roche

Completed

A Study of Subcutaneous Mircera for the Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis

Anemia

France
RESCUe - RESeau Cardiologie Urgence / RESUVal -...
Hospices Civils de Lyon

Unknown

Accessibility of Prophylaxis and On-demand Treatment for Persons With Haemophilia and Other Coagulation Deficiencies (PHAREO)

Health Services Accessibility | Blood Coagulation Factor Deficiencies

France
Theradial

Unknown

Influence of the PEPA Membrane on the Undernutrition Syndrome Inflammation in Chronic Hemodialysis (NutriPEPA2)

ESRD

France, Monaco
Hoffmann-La Roche

Completed

A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)

Chronic Renal Anemia

Belgium, Brazil, United Kingdom, Serbia, Spain, Germany, Korea, Republic of, Turkey, Lithuania, Italy, Czechia, Argentina, Australia, Croatia, France, Greece, Israel, Malaysia, Mexico, Panama, Philippines, Poland, Russian Federation, ... and more
Hospices Civils de Lyon

Completed

Prevalence Study : Elderly Patients and Rehabilitation in ICU. Impact of Frailty. (FRAGIREA)

Resuscitation

France, Mayotte
Hoffmann-La Roche

Completed

A Study to Assess Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Participants Not in Dialysis Treated With Methoxy Polyethylene Glycol-Epoetin Beta (COMETE)

Renal Anemia of Chronic Kidney Disease

France
Hoffmann-La Roche

Completed

A Study of Monthly Subcutaneous (SC) Mircera for Maintenance Treatment of Participants With Chronic Kidney Disease on Peritoneal Dialysis (MISTRAL)

Anemia

France
GlaxoSmithKline

Completed

Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)

Thrombosis, Venous

Netherlands, Spain, Germany, Italy, Poland, Russian Federation, France, Israel, Estonia, Hungary, Slovakia, Latvia, Greece, Ukraine, Czech Republic, Switzerland, Bulgaria
Centre Hospitalier Universitaire de Saint Etienne

Completed

Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy (NIGA-RA)

IgA Nephropathy

France
GlaxoSmithKline

Completed

Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States, Australia, France, Romania, Finland, Taiwan, Bulgaria, Estonia, Canada, Netherlands, Philippines, South Africa, Sweden, Spain, Singapore, Austria, Germany, Latvia, New Zealand, China, Ukraine, Thailand, Greece, United Kingdom and more
Hoffmann-La Roche

Completed

An Observational Study of Hemoglobin Stability in Chronic Kidney Disease Patients on Dialysis Treated With Mircera (Methoxy Polyethylene Glycol-epoetin Beta)

Anemia

France
Hoffmann-La Roche

Completed

A Study of Epoetin Beta (NeoRecormon) in Anemic Participants With Diabetes and Chronic Renal Failure Who Are Not on Dialysis

Anemia

France
Biotronik SE & Co. KG

Completed

Assessment of Intracardiac Electrograms Transmitted by Home Monitoring for the Remote Follow-up of Pacemaker (PREMS) (PREMS)

Bradycardia

France
Hoffmann-La Roche

Completed

An Observational Study of Patients' Perception of Treatment With Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease Not on Dialysis (PERCEPOLIS)

Anemia

France
University Hospital, Bordeaux

Completed

Improvement of Humoral Immune Response With Hemodialysis on BK-F Membrane: Correlation to Soluble CD40 Clearing (HEPADIAL)

Chronic Renal Failure | Humoral Immune Alterations

France
Boehringer Ingelheim

Completed

Telmisartan 80mg+Hydrochlorothiazide (HCTZ) 25 mg in Hypertension: an Observational Study

Hypertension

France
Amgen

Completed

Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease

Anemia | Chronic Kidney Disease

France, Italy, United Kingdom, Belgium, Hungary, Spain, Israel, Portugal, Bulgaria, Serbia, Poland, Romania, Greece, Australia, Denmark, Russian Federation, Slovakia, Germany, Latvia, Estonia, Slovenia, Czech Republic, Mexico
AstraZeneca

Completed

Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in France

Healthy

France
AstraZeneca

Completed

Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma (ASMAVIE)

Persistent Asthma

France
AstraZeneca

Completed

Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease (PLANET 1)

Diabetes Mellitus

United States, Brazil, Bulgaria, France, Italy, Mexico, Hungary, Romania, Denmark, Argentina, Canada
Centre Hospitalier Universitaire de Saint Etienne
GlaxoSmithKline

Completed

Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux. (PROPICE)

Major Orthopaedic Surgery and Renal Impairment

France
AstraZeneca

Completed

AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)

Renal Failure

Sweden, Bulgaria, Czech Republic, France, Poland, United Kingdom, Germany, Hungary, Finland, Netherlands, Norway, Canada, Mexico, Australia, Austria, Belgium, Denmark, Greece, Italy, Iceland, Brazil, Switzerland, Ireland, Korea, Republic... and more
AstraZeneca

Completed

Evaluation of Target Organs Damage in Hypertensive Patients (PreVENT-A GP)

Hypertensive | Target Organs Damage | no Known Cardiovascular | no Known Renal Disease

France
AstraZeneca

Completed

Local Phase 4 Pan-European SMART Study

Asthma

Italy, Sweden, France, Russian Federation, Spain, United Kingdom, Germany, Finland, Norway, Belgium, Netherlands, Greece, Ireland, Iceland
Centre Hospitalier Universitaire de Saint Etienne

Completed

Pharmacokinetics of Fondaparinux in Patients With Major Orthopedic Surgery (POP-A-RIX)

Orthopedic Surgery

France
AstraZeneca

Completed

National Survey on GERD Patients (Adults and Children) (RGO à trav)

GERD (Gastroesophageal Reflux Disease)

France
AstraZeneca

Completed

European Study of Cardiovascular Risk (EURIKA)

Smoking | Hypertension | Obesity | Diabetes | Hyperlipidemia | Cardiovascular Risk Factors

Sweden, France, Russian Federation, Spain, Turkey, United Kingdom, Germany, Norway, Austria, Belgium, Switzerland, Greece
AstraZeneca

Completed

National Survey on Gastroesophageal Reflux Disease (GERD) Patients (LINEA)

GERD

France
AstraZeneca

Completed

National Survey on Hypertension in General Practitioner (GP) Consultation (Prophyl GP)

Hypertension

France
AstraZeneca

Completed

National Survey on Dyslipidemic Patients (PRYSME)

Dyslipidemia

France
AstraZeneca

Completed

National Survey on Hypertension (SERENITE)

Hypertension

France

Search clinical trials for: Annona Muricata

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations